1. (valid email required)
 

cforms contact form by delicious:days

Archive for January, 2016

Health IT Outcomes: Partnership Streamlines Submission of Preadmission Screening Forms

Curaspan and the state of Virginia have announced a partnership to automate the submission of preadmission screening (PAS) forms. Read more from Health IT Outcomes here.

Health IT Outcomes: Partnership Streamlines Submission of Preadmission Screening Forms
Curaspan and the state of Virginia have announced a partnership to automate the submission of preadmission screening (PAS) forms. Read more from Health IT Outcomes here. »

Binding Site Slashes Production Time and Saves Hundreds of Thousands of Dollars with Datawatch Self-Service Data Preparation

Bedford, MA—Binding Site, the world leader in special protein diagnostics, is saving hundreds of man-hours daily and hundreds of thousands of dollars annually automating data processing in its research using data preparation software from Datawatch Corporation (NASDAQ-CM: DWCH).

Binding Site supplies the world’s laboratories with clinical diagnostic tools to diagnose and monitor specific cancers and immune disorders. During production, it must constantly analyze the results of its scientific instruments while producing a meticulous audit trail of data to comply with FDA regulations.

 

The company used to have to re-key test results from print-outs generated by its scientific laboratory instruments into a spreadsheet, manually correcting and verifying each entry before the results could be officially vetted and archived. Since Binding Site runs approximately 155 experiments per day across 40 machines, data processing had become an enormous and costly time-sink.

“The process was laborious and cumbersome, requiring on average two man-hours per experiment, which is time that could be saved,” said Dr. Adeel Mushtaq, Head of Production Control at Binding Site.

When Binding Site recently modernized its business operations with a new ERP system, Ian Rocky the IT Manager saw an opportunity to apply Datawatch’s self-service data preparation technology to save time and meet requirements.

Datawatch pulls in data from a wide range of unstructured and multi-structured data formats like PDF, XML, HTML, text, spool and ASCII files that are typically too challenging to integrate into analytical applications. Binding Site uses Datawatch to automate the reading of PDF output files captured by the ERP system from the instrumentation, identifying fields and updating an Oracle database.

Long term, by eliminating manual data preparation processes, Binding Site will save greater than $600,000 annually by reducing labor time alone in addition to improving data workflow.

“And beyond the time and cost savings, Datawatch has accelerated our ability to gather data. Our business processes will be improved thanks to our ability to automate the capture of instrument data, speed the flow of business information, and meet quality & regulatory requirements much more easily,” Mushtaq added.

“Binding Site is the perfect example of how organizations can drive efficiencies, save money and improve regulatory compliance and auditing with automation. While other companies spend up to 80 percent of their analysts’ time on data preparation, typically with many errors, Binding Site is quickly transforming raw information into reliable, consistent data sets ready for data analysis and reporting,” said Dan Potter, chief marketing officer at Datawatch.

 

 

About Binding Site
Binding Site is committed to improving patient lives worldwide through education, collaboration and innovation. The company focuses on research, development, manufacture and distribution of innovative immunodiagnostic systems and assays for the global laboratory market. By utilizing its specialized expertise in antibody specificity technology, Binding Site has developed a broad menu of special protein assays, including the Freelite® test, the only FDA cleared and guideline-recommended serum free light chain assay on the market. Binding Site gives clinicians and laboratory staff the tools to significantly improve diagnosis and management of those patients with specific cancers and immune disorders.

 

About Datawatch Corporation
Datawatch Corporation (NASDAQ-CM: DWCH) enables ordinary users to deliver extraordinary results with all their data.  Only Datawatch can unlock data from the widest variety of sources and prepare it for use with visualization tools or other business processes.  When real-time visibility to rapidly changing data is critical, Datawatch enables you to visualize streaming data for the most demanding business environments such as capital markets. Organizations of every size worldwide use Datawatch products including 93 of the Fortune 100. Datawatch is headquartered in Bedford, Massachusetts with offices in New York, London, Frankfurt, Stockholm, Singapore, and Manila, and with partners and customers in more than 100 countries worldwide.  See how Datawatch can help you by downloading a free version atwww.datawatch.com.

 

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any such statements contained herein, including but not limited to those relating to product performance and viability, are based on current expectations, but are subject to a number of risks and uncertainties that may cause actual results to differ materially from expectations. The factors that could cause actual future results to differ materially from current expectations include the following: rapid technological change; Datawatch’s dependence on the introduction of new products and product enhancements and possible delays in those introductions; acceptance of new products by the market, competition in the software industry generally, and in the markets for next generation analytics in particular; and Datawatch’s dependence on its principal products, proprietary software technology and software licensed from third parties. Further information on factors that could cause actual results to differ from those anticipated is detailed in various publicly-available documents, which include, but are not limited to, filings made by Datawatch from time to time with the Securities and Exchange Commission, including but not limited to, those appearing in the Company’s Annual Report on Form 10-K for the year ended September 30, 2015. Any forward-looking statements should be considered in light of those factors.

Binding Site Slashes Production Time and Saves Hundreds of Thousands of Dollars with Datawatch Self-Service Data Preparation
Bedford, MA—Binding Site, the world leader in special protein diagnostics, is saving hundreds of man-hours daily and hundreds of thousands of dollars annually automating data processing in its research using data preparation software from Datawatch Corporation (NASDAQ-CM: DWCH). Binding Site supplies the world’s laboratories with clinical diagnostic tools to diagnose and monitor specific cancers and immune disorders. During […] »

Datawatch and Tableau Partner to Speed and Broaden Analytics with Self-Service Data Preparation

Bedford, MA  – Datawatch Corporation (NASDAQ-CM: DWCH) has partnered with Tableau Software to help business analysts make faster and better decisions.

With Datawatch Monarch natively supporting Tableau’s data format (TDE), user productivity skyrockets because they can now independently access, manipulate and blend any kind of data from virtually any source, in a fraction of the time that it takes using spreadsheets and brute force.

The partnership also benefits Tableau partners by enabling them to deploy customer projects faster with reusable and automated preparation processes. Partners can offer increased service engagement opportunities with Datawatch by delivering a comprehensive enterprise solution including governance for self-service analytics that spans data retention, auditing and masking.

“Tableau helps people to see and understand their data. Yet, preparing and blending disparate data often takes longer than the data analysis process,” said Dan Kogan, Director of Product Marketing at Tableau. “This partnership will enable faster decision making from the widest variety of data sources in minutes or hours, not days or weeks.”

Access to a wider variety of previously inaccessible data is another significant advantage for Tableau users. Datawatch is unique in its ability to access and prepare data from semi-structured sources such as PDF files, web pages, log files, JSON, telemetry data, print spools, text, CSV, EDI, and even BI reports created by third party tools and legacy systems.

“Better decisions come from analyzing the right data. Unfortunately, this data is not always accessible or in a format that Tableau can accept. In fact, it is estimated that only 12 percent of enterprise data is used today to make decisions. Datawatch and Tableau aim to change that by unlocking all of the data needed,” said Dan Potter, chief marketing officer at Datawatch.

See the Tableau/Datawatch solution in action at the Tableau Partner Summit

Datawatch announced the partnership and demonstrated the power of their technology integration today at the Tableau Partner Summit 2016 in Austin, Texas.

 

 

About Datawatch Corporation

Datawatch Corporation (NASDAQ-CM: DWCH) provides the only Managed Analytics Platform that brings together self-service data preparation with visual data discovery. Its software bridges the gap between the ease that business user’s demand and the automation and governance needed by IT. Users can quickly discover key factors that improve their business by transforming data from multi-structured sources, as well as real-time streaming data, into visually rich analytic applications. Organizations of every size, worldwide use Datawatch products, including 93 of the Fortune 100. Datawatch is headquartered in Chelmsford, Massachusetts with offices in New York, London, Frankfurt, Stockholm, Singapore, Melbourne and Manila, and with partners and customers in more than 100 countries worldwide. Learn more at www.datawatch.com. For investor relations information, visitinvestor.datawatch.com.

 

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any such statements contained herein, including but not limited to those relating to product performance and viability, are based on current expectations, but are subject to a number of risks and uncertainties that may cause actual results to differ materially from expectations. The factors that could cause actual future results to differ materially from current expectations include the following: rapid technological change; Datawatch’s dependence on the introduction of new products and product enhancements and possible delays in those introductions; acceptance of new products by the market, competition in the software industry generally, and in the markets for next generation analytics in particular; and Datawatch’s dependence on its principal products, proprietary software technology and software licensed from third parties. Further information on factors that could cause actual results to differ from those anticipated is detailed in various publicly-available documents, which include, but are not limited to, filings made by Datawatch from time to time with the Securities and Exchange Commission, including but not limited to, those appearing in the Company’s Annual Report on Form 10-K for the year ended September 30, 2015. Any forward-looking statements should be considered in light of those factors.

Datawatch and Tableau Partner to Speed and Broaden Analytics with Self-Service Data Preparation
Bedford, MA  – Datawatch Corporation (NASDAQ-CM: DWCH) has partnered with Tableau Software to help business analysts make faster and better decisions. With Datawatch Monarch natively supporting Tableau’s data format (TDE), user productivity skyrockets because they can now independently access, manipulate and blend any kind of data from virtually any source, in a fraction of the time that it […] »

Xcede Technologies Announces Collaboration with Cook Biotech Inc.

ROCHESTER, Minn., /PRNewswire/ — Xcede Technologies, Inc. today announced that it has signed three collaboration agreements with Cook Biotech Inc. ofWest Lafayette, IN including a Development Agreement, a License Agreement and a Supply Agreement to complete development, seek regulatory clearance and produce Xcede’s resorbable hemostatic patch.

Xcede Technologies, a subsidiary of Dynasil Corporation of America (“DCA”), is based inRochester, MN and Seattle, WA and began operations in October 2013 following a technology transfer from Dynasil Biomedical, a subsidiary of DCA.

Xcede is committed to the development and manufacturing of innovative hemostatic and sealant products to control severe bleeding in surgical applications.  Xcede’s resorbable hemostatic patch is currently under development and the Company is anticipating starting clinical trials in early 2017.

“We are excited to announce this collaboration with Cook Biotech,” said Linda Zuckerman, Ph.D., President and CEO of Xcede Technologies., Inc.  “We believe that Cook’s experience and depth in the marketplace will provide a solid foundation for bringing our hemostatic patch into clinical development and on to regulatory approval and commercial sales.”

Umesh Patel, Ph.D., Vice President & General Manager of Cook Biotech Inc., states, “Cook’s SIS matrix technology combined with Xcede’s adhesive technology provides an excellent foundation for Xcede’s first product and the basis for potential expansion to other products to be commercialized with Cook.  We are excited to announce this collaboration with Xcede Technologies.”

Safe Harbor 

This news release may contain forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  These forward-looking statements regarding future events and our future results are based on current expectations, estimates, forecasts, and projections and the beliefs and assumptions of our management, including, without limitation, our expectations regarding results of operations, the commercialization of our technology, in particular the Xcede patch, the success of efforts to fund Xcede, positive outcomes of our pre-clinical and planned clinical trials, regulatory approvals and the strength of our intellectual property portfolio.  These forward-looking statements may be identified by the use of words such as “plans”, “intends,” “may,” “could,” “expect,” “estimate,” “anticipate,” “continue” or similar terms, though not all forward-looking statements contain such words.  The actual results of the future events described in such forward looking statements could differ materially from those stated in such forward looking statements due to a number of important factors. These factors that could cause actual results to differ from those anticipated or predicted include, without limitation, our ability to develop and commercialize the Xcede patch, including obtaining regulatory approvals, the size and growth of the potential markets for our products and our ability to serve those markets, the rate and degree of market acceptance of any of our products, general economic conditions, costs and availability of raw materials and management information systems, our ability to obtain and maintain intellectual property protection for our products, competition, the loss of key management and technical personnel, our ability to obtain timely payment of our invoices to governmental customers, litigation, the effect of governmental regulatory developments, the availability of financing sources, our ability to identify and execute on acquisition opportunities and integrate such acquisitions into our business, and seasonality, as well as the uncertainties set forth in Dynasil Corporation of America’s (NASDAQ: DYSL) Annual Report on Form 10 K, as filed on December 17, 2015 and from time to time in the Company’s other filings with the Securities and Exchange Commission. Dynasil Corporation of America disclaims any intention or obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Dynasil Corporation of America disclaims any intention or obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Xcede Technologies Announces Collaboration with Cook Biotech Inc.
ROCHESTER, Minn., /PRNewswire/ — Xcede Technologies, Inc. today announced that it has signed three collaboration agreements with Cook Biotech Inc. ofWest Lafayette, IN including a Development Agreement, a License Agreement and a Supply Agreement to complete development, seek regulatory clearance and produce Xcede’s resorbable hemostatic patch. Xcede Technologies, a subsidiary of Dynasil Corporation of America (“DCA”), is […] »

January 2016 – Mass Capital announces a new investment in Phillips Screw Company

PHILLIPS SCREW COMPANY

Based in Burlington, Massachusetts, Phillips Screw Company is a leading designer and distributor of fasteners commonly used throughout the world across a wide variety of end markets including building products, aerospace, automotive and industrial applications. Phillips Screw Company was originally founded in 1935 when the Company released the original Phillips crosshead screw. Since then, Phillips has designed a variety of innovative drive systems and remains a well-known brand in the industry. Mass Capital’s subordinated debt and equity investment, along with equity sponsorship by Gemini Investors of Wellesley, MA, financed the management buyout of the Company from long time individual owners.

For more information on Phillips Screw Company, please visit www.phillips-screw.com.

January 2016 – Mass Capital announces a new investment in Phillips Screw Company
PHILLIPS SCREW COMPANY Based in Burlington, Massachusetts, Phillips Screw Company is a leading designer and distributor of fasteners commonly used throughout the world across a wide variety of end markets including building products, aerospace, automotive and industrial applications. Phillips Screw Company was originally founded in 1935 when the Company released the original Phillips crosshead screw. […] »

Latest News

Datawatch Self-Service Data Preparation Platform in High Demand in Healthcare Market

NWN Recognized in CRN Elite 150 For Managed IT Services and Placed on Managed Service Provider 500 List

Bigbelly Unveils Top 2016 Successes for Optimized Collections & Recycling Diversion

Southern California Edison Awards Cadmus MSA to Support Zero Net Energy Schools

» More News


Latest Newsletters

April 2017 – MCRC Announces a New Investment in Baynes Electric Supply

March 2017 – Mass Capital Announces a New Investment in Tri-Wire Engineering Solutions, Inc.

July 2016 – Mass Capital Announces a New Investment in The Cadmus Group, Inc.

» More Newsletters


Archives!